Other · 5 May 2021
CommentaryPublished 27 Nov 2012
Neurogenetics and Nutrigenomics of Neuro-Nutrient Therapy for Reward Deficiency Syndrome (RDS): Clinical Ramifications as a Function ofMolecular Neurobiological Mechanisms
Department of Psychiatry, University of Florida, McKnight Brain Institute, Gainesville, Fl, USA; Departments of Psychiatry, Neurology, and Anatomy & Neurobiology, Boston University of School of Medicine, Boston, MA, USA; Union Memorial Hospital, Baltimore, MD and Amen Clinics, Baltimore, MD, USA; LifeStream, Inc. St. Louis, MO, USA; Department of Nutrigenomic, LifeGen, Inc. San Diego, CA, USA; Department of Holistic Medicine, G&G Holistic Addiction Treatment Center, North Miami Beach, Fl, USA; Integrative Life Center of Nashville, Tennessee, USA; Center for Genomics and Applied Gene Technology, Institute of Integrative Omics and applied Biotechnology (IIOAB), Nonakuri, Purbe Medinpur, West Bengal, India; Northwest Resources, Olympia, Washington, USA; Path Foundation NY, New York, New York USA; Malibu Beach Recovery Center, Malibu Beach, California, USA; Dominion Diagnostics, North Kingstown Rhode Island, USA; Department of Management Science and Statistics, University of Texas at San Antonio, San Antonio, Texas, USA; Medical Director for Marion County Methadone Clinic, Salem Oregon, USA; Global Integrated Services Unit University of Vermont Center for Clinical & Translational Science, College of Medicine, Burlington, VT, USA
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
In accord with the new definition of addiction published by American Society of Addiction Medicine (ASAM) it is well-known that individuals who present to a treatment center involved in chemical dependency or other documented reward dependence behaviors have impaired brain reward circuitry. They have hypodopaminergic function due to genetic and/or environmental negative pressures upon the reward neuro-circuitry. This impairment leads to aberrant craving behavior and other behaviors such as Substance Use Disorder (SUD). Neurogenetic research in both animal and humans revealed that there is a well-defined cascade in the reward site of the brain that leads to normal dopamine release. This cascade has been termed the “Brain Reward Cascade” (BRC). Any impairment due to either genetics or environmental influences on this cascade will result in a reduced amount of dopamine release in the brain reward site. Manipulation of the BRC has been successfully achieved with neuro-nutrient therapy utilizing nutrigenomic principles. After over four decades of development, neuro-nutrient therapy has provided important clinical benefits when appropriately utilized. This is a review, with some illustrative case histories from a number of addiction professionals, of certain molecular neurobiological mechanisms which if ignored may lead to clinical complications.
Keywords
Subjects
Mental Health and PsychologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Commentary · 5 Jul 2014
Buprenorphine Response as a Function of Neurogenetic Polymorphic Antecedents: Can Dopamine Genes Affect Clinical Outcomes in Reward Deficiency Syndrome (RDS)?
Conference abstract · 22 Jun 2013
Genetic Addiction Risk Scores (GARS) coupled with the Comprehensive Analysis of Reported Drugs (CARD) provide diagnostic and outcome data supporting the need for dopamine D2 agonist therapy: Proposing a holistic -therapeutic model for Reward Deficiency Syndrome (RDS)
Editorial · 2012
Neurogenetic Impairments of Brain Reward Circuitry Links to Reward Deficiency Syndrome (RDS): Potential Nutrigenomic Induced Dopaminergic Activation
Perspective · 29 Jun 2023
Evidence for the Drd2 Gene as a Determinant of Reward Deficiency Syndrome (RDS)
More from this journal
The newest in Journal of Addiction Research & Therapy.
Commentary · 28 Feb 2026
Regional Drink Bacanora from a Gender Perspective
Research article · 31 Dec 2025
Association between Depressive Symptoms and Lifetime Cannabis Use among American Adolescents: Analysis of 2022 National Surveys on Drug Use and Health
Opinion · 30 Jun 2025
Public Health Implications of Cannabis Legalization: A Post-Legislation Trend Analysis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Addiction Research & Therapy
- SubjectMental Health and Psychology
- BylineArticles whose byline prints “Kenneth Blum”
- BylineArticles whose byline prints “Marlene Oscar- Berman”
- BylineArticles whose byline prints “Elizabeth Stuller”
- BylineArticles whose byline prints “David Miller”
- BylineArticles whose byline prints “John Giordano”
- BylineArticles whose byline prints “Siobhan Morse”
- BylineArticles whose byline prints “Lee McCormick”
- BylineArticles whose byline prints “William Downs B”
